Subrogation

Subrogation in insurance is the process by which an insurance company that has paid a claim on behalf of its insured seeks to recover the amount of the claim from a third party who may be responsible for the loss or damage. In other words, subrogation allows the insurer to step into the shoes of its insured and seek reimbursement from another party.

For example, if you are involved in an auto accident and your insurance company pays for the damages to your car, your insurance company may then seek reimbursement from the other driver's insurance company, if the other driver was at fault for the accident.

Key features of subrogation include:

  • It is a common practice in the insurance industry to help reduce costs for insurers and their policyholders.
  • The insurance company may have the right to recover the amount of the claim, as well as any costs associated with pursuing the claim, such as legal fees.
  • The insurance company must have paid a claim on behalf of its insured in order to have the right to seek reimbursement through subrogation.
  • Subrogation can occur in various types of insurance claims, including property damage, personal injury, and healthcare claims.
  • The right to subrogation may be included in the insurance policy or may be granted by law in certain circumstances.
  • Subrogation can also be waived or limited by agreement between the parties involved, such as in a settlement agreement.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.